DERIVATIVE FINANCIAL INSTRUMENTS (Details Narrative) |
Mar. 31, 2022
USD ($)
|
Dec. 31, 2021
USD ($)
|
Oct. 30, 2020
USD ($)
$ / shares
shares
|
Feb. 28, 2020
$ / shares
shares
|
Jan. 06, 2020
USD ($)
$ / shares
shares
|
Jan. 02, 2020
$ / shares
shares
|
May 18, 2018
USD ($)
$ / shares
shares
|
|---|---|---|---|---|---|---|---|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||
| Derivative liability | $ 5,069 | $ 22,554 | |||||
| Amended and Restated Loan Agreement [Member] | |||||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||
| Warrants to acquire of common stock | shares | 320,000 | ||||||
| Warrant exercise price | $ / shares | $ 0.10 | ||||||
| Derivative liability | $ 30,012 | ||||||
| Loan Agreement [Member] | |||||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||
| Warrants to acquire of common stock | shares | 5,000,000 | 200,000 | 5,000,000 | 5,000,000 | |||
| Warrant exercise price | (per share) | $ 0.10 | $ 0.10 | $ 0.10 | $ 0.10 | |||
| Derivative liability | $ 95,352 | $ 144,259 |